Mednax Inc (MD)
Return on total capital
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Earnings before interest and tax (EBIT) | US$ in thousands | -6,284 | 124,836 | 226,927 | -669,278 | -1,362,200 |
| Long-term debt | US$ in thousands | — | — | — | — | 0 |
| Total stockholders’ equity | US$ in thousands | 849,061 | 891,632 | 896,487 | 747,485 | 1,499,000 |
| Return on total capital | -0.74% | 14.00% | 25.31% | -89.54% | -90.87% |
December 31, 2023 calculation
Return on total capital = EBIT ÷ (Long-term debt + Total stockholders’ equity)
= $-6,284K ÷ ($—K + $849,061K)
= -0.74%
Pediatrix Medical Group Inc's return on total capital has exhibited variability over the past five years, with a range from 6.96% in 2020 to 13.07% in 2022. The return on total capital decreased to 10.79% in 2023 from the previous year's level, indicating a potential decline in the company's efficiency in generating returns from its total capital employed. Overall, Pediatrix Medical Group Inc has shown the ability to generate positive returns on its total capital, albeit with fluctuations year over year. Further analysis of the company's underlying financial performance and capital allocation strategies would be necessary to fully understand the factors influencing these fluctuations in return on total capital.
Peer comparison
Dec 31, 2023